LENZ Therapeutics (LENZ) Interest & Investment Income (2023 - 2026)
LENZ Therapeutics (LENZ) reported Interest & Investment Income of $2.6 million for Q1 2026, up 13.82% year-over-year from $2.3 million in Q1 2025, and down 11.45% on a QoQ basis from $3.0 million in Q4 2025.
LENZ Therapeutics (LENZ) has 4 years of Interest & Investment Income data on file, last reported at $2.6 million in Q1 2026.
- Quarterly Interest & Investment Income rose 13.82% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (changed 0.11% YoY) and the FY2025 annual result came in at $9.8 million, up 14.07% from the prior year.
- Interest & Investment Income declined to $2.6 million in Q1 2026 per LENZ's latest filing, from $3.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.0 million in Q4 2025 and bottomed at $251000.0 in Q2 2023.
- The 4-year median for Interest & Investment Income is $2.3 million (2025), against an average of $1.9 million.
- The widest annual swing landed in 2024, when Interest & Investment Income soared 881.27%; it then decreased 19.55% in 2025.
- Tracing LENZ's Interest & Investment Income over 4 years: stood at $851000.0 in 2023, then jumped by 201.53% to $2.6 million in 2024, then climbed by 16.37% to $3.0 million in 2025, then declined by 11.45% to $2.6 million in 2026.
- Per Business Quant, the three latest LENZ Interest & Investment Income figures stand at $2.6 million (Q1 2026), $3.0 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 788,000.00 |
| Dec 31, 2023 | 851,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 251,000.00 |